# Pharmaceutics International, INC. 401(k) Plan
Source: https://planprovider.pro/companies/pharmaceutics-international-inc-plan-001

> Pharmaceutics International, INC.&#39;s 401(k) plan: 298 participants, plan year 2024 financials, providers, and benchmarks from Form 5500.

Form 5500 filing data for plan year 2024.

## Plan Snapshot

- **Plan Sponsor:** Pharmaceutics International, INC.

- **Sponsor EIN:** 521901342

- **Sponsor Address:** 10819 GILROY RD, HUNT VALLEY, MD, 210318213

- **Plan Type:** 401(k)

- **Total Participants:** 298

- **Total Assets:** $21.1M

## Key Plan Design Features

- **Auto-Enrollment:** No

- **Auto-Escalation:** No

- **Allows Roth Contributions:** Yes

- **Participant Loans:** No

- **Participant-Directed Investments:** Yes

- **ERISA Section 404(c) Fiduciary Safe Harbor:** Yes

## Plan Financials by Year

| Year|Participants|Total Assets|Employer Contrib.|Employee Contrib.|

| 2024|298|$21.1M|$1.0M|$2.0M|

| 2023|292|$18.7M|$867,849|$1.6M|

| 2022|242|$17.4M|$710,978|$1.4M|

## Service Providers (Schedule C)

Vendors paid $5,000 or more for services to the plan, ranked by total compensation (direct + indirect fees).

| Provider Name|
Role|
Direct Compensation|
Indirect Compensation|
Total Fees|

| ELLIN AND TUCKER|Auditor|—|—|$0|

## Plan Fees & Expenses

Annual service provider fees and administrative expenses sourced from DOL Form 5500 filings.

- **Total Service Provider Fees:** $0

### Historical Administrative Expenses

Breakdown of administrative expense categories reported on Form 5500 filings.

| Year|
Total Admin Expenses|
Investment Mgmt Fees|
Contract Admin Fees|
IQPA Audit Fees|
Professional Fees|

| 2024|$76,902|$11,793|$45,454|—|—|

| 2023|$67,463|$10,451|$39,594|—|—|

| 2022|$67,708|$10,969|$38,458|—|$18,281|

## Similar Plans

- [Origene Technologies, INC.](https://planprovider.pro/companies/origene-technologies-inc-401k-plan) — 159 participants

- [Ascentage Pharma Group INC.](https://planprovider.pro/companies/ascentage-pharma-group-inc-401k-plan) — 87 participants

- [Emergent Biosolutions, INC.](https://planprovider.pro/companies/emergent-biosolutions-inc-401k-plan) — 531 participants

- [Elutia INC.](https://planprovider.pro/companies/aziyo-biologics-inc-401k-plan) — 49 participants

- [Igc Pharma, INC.](https://planprovider.pro/companies/igc-pharma-inc-401k-plan) — 25 participants

- [Northwest Biotherapeutics, INC.](https://planprovider.pro/companies/northwest-biotherapeutics-inc-plan) — 23 participants

[View full interactive plan profile on PlanProvider.Pro](https://planprovider.pro/companies/pharmaceutics-international-inc-plan-001)

&copy; 2026 PlanProvider.Pro
